Stefanie Deuster
Impact in
-
- Antibiotic Use and Resistance
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Nanoparticle-Based Drug Delivery 3
-
- Pain Management and Placebo Effect 2
- Co-authors
- Reto Ritschard (3 shared papers)Christoph Rochlitz (3 shared papers)Christoph Mamot (3 shared papers)Andreas Wicki (2 shared papers)Thomas Dieterle (2 shared papers)Lukas Bubendorf (2 shared papers)Richard Herrmann (1 shared paper)M Gloor (2 shared papers)
- Journals
- PLoS ONE (2 papers)Trials (1 paper)Journal of Clinical Oncology (1 paper)International Journal of Pharmaceutics (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- SwitzerlandCanadaUnited Kingdom
In The Last Decade
Stefanie Deuster
14 papers receiving 373 citations
Peers
Comparison fields: 5 of 97
- Applied Microbiology and Biotechnology 26
- Biomaterials 146
- Medical Terminology 1
- Anesthesiology and Pain Medicine 18
- Geriatrics and Gerontology 10
Countries citing papers authored by Stefanie Deuster
This map shows the geographic impact of Stefanie Deuster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Deuster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Deuster more than expected).
Fields of papers citing papers by Stefanie Deuster
This network shows the impact of papers produced by Stefanie Deuster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Deuster. The network helps show where Stefanie Deuster may publish in the future.
Co-authors
The 25 scholars most cited alongside Stefanie Deuster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 179 | |
| 2 | 2016 | 65 | |
| 3 | 2009 | 38 | |
| 4 | 2015 | 31 | |
| 5 | 2012 | 26 | |
| 6 | 2011 | 11 | |
| 7 | 2011 | 9 | |
| 8 | 2020 | 7 | |
| 9 | 2017 | 4 | |
| 10 | 2015 | 3 | |
| 11 | 2019 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 1 | |
| 14 | 2021 | 1 |
About Stefanie Deuster
Stefanie Deuster is a scholar working on Biomaterials, Cognitive Neuroscience, Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 14 papers that have together received 378 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (3 papers), HER2/EGFR in Cancer Research (2 papers), Pharmaceutical studies and practices (2 papers), Pain Management and Placebo Effect (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Muscle Physiology and Disorders (2 papers), Electrochemical sensors and biosensors (1 paper) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (26 citations), Biomaterials (146 citations), Medical Terminology (1 citation), Anesthesiology and Pain Medicine (18 citations) and Geriatrics and Gerontology (10 citations). Stefanie Deuster has collaborated with scholars based in Switzerland, Canada and United Kingdom. Frequent co-authors include Reto Ritschard, Christoph Rochlitz, Christoph Mamot, Andreas Wicki, Thomas Dieterle, Lukas Bubendorf, Richard Herrmann, M Gloor, Patricia Hafner and Dirk Fischer. Their work appears in journals such as PLoS ONE, Trials, Journal of Clinical Oncology, International Journal of Pharmaceutics and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.